Levetiracetam in patients with refractory epilepsy: Results of the SKATE trial in Austria, Germany and Switzerland

Seizure

Volumn 14, Issue 7, 2005, Pages 490-496

  Steinhoff, Bernhard J ^a   Trinka, Eugen ^b   Wieser, Heinz Gregor ^c  

^a EPILEPSIEZENTRUM KORK   (Germany)

^b Universitatsklinik fur Neurochirurgie Innsbruck   (Austria)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Add on treatment; Community based trial; Levetiracetam; Partial seizures; Refractory epilepsy

Indexed keywords

ANTICONVULSIVE AGENT; ETIRACETAM;

ADD ON THERAPY; ADOLESCENT; ADULT; AGED; ARTICLE; ASTHENIA; AUSTRIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DIZZINESS; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOCAL EPILEPSY; GERMANY; HEADACHE; HOSTILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; OPEN STUDY; OPTIMAL DRUG DOSE; PHASE 4 CLINICAL TRIAL; PRIORITY JOURNAL; RELAPSE; SEIZURE; SIDE EFFECT; SOMNOLENCE; SWITZERLAND; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; AUSTRIA; DEMOGRAPHY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG EVALUATION; EPILEPSY; FEMALE; GERMANY; HUMANS; MALE; MIDDLE AGED; PIRACETAM; SWITZERLAND; TIME FACTORS; TREATMENT OUTCOME;

EID: 27644581759     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.seizure.2005.08.005     Document Type: Article

References (14)

1. G.A. Baker C. Camfield P. Camfield J.A. Cramer C.E. Elger A.L. Johnson et al. ILAE Commission report. Commission on outcome measurement in epilepsy, 1994-1997: Final report Epilepsia 39 1998 213-231
2. E. Ben-Menachem U. Falter European Levetiracetam Study Group Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory focal seizures: A multicenter, double-blind, responder-selected study evaluating monotherapy Epilepsia 41 2000 1276-1283
3. J.J. Cereghino V. Biton B. Abou-Khalil F. Dreifuss L.J. Gauer I. Leppik United States Levetiracetam Study Group Levetiracetam for partial seizures: Results of a double-blind, randomized clinical trial Neurology 55 2000 236-242
4. Commission on Classification Terminology of the International League Against Epilepsy Proposal for revised clinical and electroencephalographic classification of epileptic seizures Epilepsia 22 1981 489-501
5. J.A. Cramer K. Perrine O. Devinsky K. Meador A brief questionnaire to screen for quality of life in epilepsy: The QOLIE-10 Epilepsia 37 1996 577-582
6. CPMP Working Party on Efficacy of Medicinal Products EEC note for guidance: Medical products for the treatment of epileptic disorders Pharmacol Toxicol 67 1990 349-352
7. H. Klitgaard A. Pitkänen Antiepileptogenesis, neuroprotection, and disease modification in the treatment of epilepsy: Focus on levetiracetam Epileptic Disord 5 Suppl. 1 2003 9-16
8. P. Kwan M.J. Brodie Early identification of refractory epilepsy New Engl J Med 342 2000 314-319
9. B.A. Lynch N. Lambeng K. Nocka P. Kensel-Hammes S.M. Bajjalieh A. Matagne et al. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam PNAS 101 2004 9861-9866
10. D.G. Margineanu H. Klitgaard In: R.H. Levy R.H. Mattson B.S. Meldrum E. Perucca editors. Antiepileptic drugs 5th ed. 2002 Lippincott Williams & Wilkins Philadelphia 419-427
11. M.J. Morrell I. Leppik J. French J. Ferrendelli J. Han L. Magnus The KEEPER™ Trial: Levetiracetam adjunctive treatment of partial onset seizures in an open-label community based study Epilepsy Res 54 2003 153-161
12. P.N. Patsalos Pharmacokinetic profile of levetiracetam: Toward ideal characteristics Pharmacol Ther 85 2000 77-85
13. E. Perucca B.E. Gidal E. Baltès Effects of antiepileptic comedication on levetiracetam pharmacokinetics: A pooled analysis of data from randomized adjunctive therapy trials Epilepsy Res 53 2003 47-56
14. S.D. Shorvon A. Löwenthal D. Janz E. Bielen P. Loiseau European Levetiracetam Study Group Multicenter, double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures Epilepsia 41 2000 1179-1186